Rafael Holdings RFL
NYSE RFL
$1.50 +0.18 (+13.64%)
As of: Oct 1, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) Liabilities and Shareholders Equity (2017 - 2026)

Updated

Rafael Holdings' Liabilities and Shareholders Equity came in at $91.99 million for fiscal Q3 2026 (quarter ended Apr 30, 2026), down 14.9% from $108.1 million a year earlier and down 7.4% from the prior quarter.

Analysis

Rafael Holdings (RFL) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

At the end of FY2025 (ended Jul 31, 2025), Rafael Holdings' Liabilities and Shareholders Equity was $114.11 million, up 17.8% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -3.5% (FY2020 to FY2025).
  • Going back by fiscal year, Liabilities and Shareholders Equity was $96.83 million in FY2024 (-2.0%), $98.83 million in FY2023 (-16.5%), $118.32 million in FY2022 (-23.2%) and $154.06 million in FY2021 (+13.0%).
  • The fiscal Q3 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since fiscal Q2 2025.
  • Year-over-year, Liabilities and Shareholders Equity increased in four of the last eight quarters, with growth averaging 2.1%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in fiscal Q1 2026 (growth of 20.0%), and the weakest in fiscal Q4 2022 (a decline of 23.2%).
  • Business Quant data shows RFL's Liabilities and Shareholders Equity at $99.32 million (Q2 2026), $105.38 million (Q1 2026) and $114.11 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Rafael Holdings 68.10 Mn 73.52 Mn 163,000.00 91.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 91.99 Mn
Jan 31, 2026 99.32 Mn
Oct 31, 2025 105.38 Mn
Jul 31, 2025 114.11 Mn
Apr 30, 2025 108.10 Mn
Jan 31, 2025 83.04 Mn
Oct 31, 2024 87.84 Mn
Jul 31, 2024 96.83 Mn
Apr 30, 2024 101.62 Mn
Jan 31, 2024 106.15 Mn
Oct 31, 2023 95.50 Mn
Jul 31, 2023 98.83 Mn
Apr 30, 2023 96.36 Mn
Jan 31, 2023 98.55 Mn
Oct 31, 2022 103.22 Mn
Jul 31, 2022 118.32 Mn
Apr 30, 2022 112.78 Mn
Jan 31, 2022 118.32 Mn
Oct 31, 2021 130.41 Mn
Jul 31, 2021 154.06 Mn
API Access

Rafael Holdings Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RFL&period=max&api_key=YOUR_API_KEY